Bausch Health
BHC
#3740
Rank
A$4.19 B
Marketcap
$11.41
Share price
1.81%
Change (1 day)
-13.72%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$4.00

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$4.15. In 2022 the company made an earnings per share (EPS) of -$0.97 an increase over its 2021 EPS that were of -$4.15.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.00312.73%
2022-$0.97-76.64%
2021-$4.1568.45%
2020-$2.46-68.91%
2019-$7.92-57.11%
2018-$18.48-272.22%
2017$10.73-199.29%
2016-$10.81798.7%
2015-$1.20-128.31%
2014$4.25-204.62%
2013-$4.06602.7%
2012-$0.58-171.15%
2011$0.81-143.96%
2010-$1.85-206.57%
2009$1.73-11.2%
2008$1.952.46%
2007$1.91-7.58%
2006$2.06-14.29%
2005$2.4054%
2004$1.56-500%
2003-$0.39-141.67%
2002$0.94-4.76%
2001$0.98-175%
2000-$1.31-268%
1999$0.7814.94%
1998$0.6820.83%
1997$0.5653.83%
1996$0.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.56-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.42-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA